TITLE

Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use

AUTHOR(S)
Moulin, Dwight E.; Johnson, Neil G.; Murray-Parsons, Nancy; Geoghegan, Margaret F.; Goodwin, Veda A.; Chester, Margaret A.
PUB. DATE
March 1992
SOURCE
CMAJ: Canadian Medical Association Journal;3/15/1992, Vol. 146 Issue 6, p891
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35470125

 

Related Articles

  • Interventional pain management in the palliative care patient. McHugh, Marlene E.; Miller-Saultz, Debbie; Wuhrman, Elsa; Kosharskyy, Boleslav // International Journal of Palliative Nursing;Oct2012, Vol. 18 Issue 10, p426 

    For the majority of patients, cancer pain can be treated using the World Health Organization cancer pain guidelines; however, for 10-20% of patients with advanced cancer, adequate pain control cannot be achieved using these methods owing to disease pathophysiology preventing...

  • Interventional pain management in the palliative care patient. Mchugh, Marlene E; Miller-Saultz, Debbie; Wuhrman, Elsa; Kosharskyy, Boleslav // International Journal of Palliative Nursing;Sep2012, Vol. 18 Issue 9, p426 

    For the majority of patients, cancer pain can be treated using the World Health Organization cancer pain guidelines; however, for 10-20% of patients with advanced cancer, adequate pain control cannot be achieved using these methods owing to disease pathophysiology preventing...

  • Fentanyl.  // AHFS Consumer Medication Information;Aug2017, p1 

    Fentanyl is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients at least 18 years of age (or at least 16 years of age if taking Actiq brand lozenges) who are taking regularly scheduled doses of another...

  • Fentanyl Nasal Spray.  // AHFS Consumer Medication Information;Aug2017, p1 

    Fentanyl nasal spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age or older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are...

  • Fentanyl Sublingual Spray.  // AHFS Consumer Medication Information;Aug2017, p1 

    Fentanyl sublingual spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age and older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are...

  • Fentanyl Sublingual Spray.  // AHFS Consumer Medication Information;Aug2017, p1 

    Fentanyl sublingual spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age and older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are...

  • Fentanyl Sublingual Spray.  // AHFS Consumer Medication Information;Aug2017, p1 

    Fentanyl sublingual spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age and older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are...

  • Fentanyl Sublingual Spray.  // AHFS Consumer Medication Information;Aug2017, p1 

    Fentanyl sublingual spray is used to treat breakthrough pain (sudden episodes of pain that occur despite round the clock treatment with pain medication) in cancer patients 18 years of age and older who are taking regularly scheduled doses of another narcotic (opiate) pain medication, and who are...

  • oxycodone.  // Royal Society of Medicine: Medicines;2002, p419 

    The article presents information on oxycodone, a powerful opioid or narcotic analgesic. It can be used in the treatment of severe pain, such as in cancer or postoperative pain. Administration is oral, suppositories are also sometimes used. All preparations are on the Controlled Drugs list.

  • Multimodal Pain Management after Total Hip and Knee Arthroplasty at the Ranawat Orthopaedic Center. Aditya Maheshwari; Yossef Blum; Laghvendu Shekhar; Amar Ranawat; Chitranjan Ranawat // Clinical Orthopaedics & Related Research;Jun2009, Vol. 467 Issue 6, p1418 

    Abstract  Improvements in pain management techniques in the last decade have had a major impact on the practice of total hip and knee arthroplasty (THA and TKA). Although there are a number of treatment options for postoperative pain, a gold standard has not been established. However,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics